Benzinga | Nov 10, 2021 07:15AM EST

TScan Therapeutics Q3 EPS $(0.80) Up From $(7.16) YoY, Sales $2.41M Up From $290.00K YoY

TScan Therapeutics (NASDAQ:TCRX) reported quarterly losses of $(0.80) per share. This is a 88.83 percent increase over losses of $(7.16) per share from the same period last year. The company reported $2.41 million in sales this quarter. This is a 731.72 percent increase over sales of $290.00 thousand the same period last year.